Back to Search
Start Over
Comparison of treatment efficacy 1 and 2 years after thyroid remnant ablation with 1110 versus 5550MBq of iodine-131 in patients with intermediate-risk differentiated thyroid cancer.
- Source :
- Nuclear Medicine Communications; Nov2017, Vol. 38 Issue 11, p927-931, 5p
- Publication Year :
- 2017
Details
- Language :
- English
- ISSN :
- 01433636
- Volume :
- 38
- Issue :
- 11
- Database :
- Complementary Index
- Journal :
- Nuclear Medicine Communications
- Publication Type :
- Academic Journal
- Accession number :
- 125934076
- Full Text :
- https://doi.org/10.1097/MNM.0000000000000730